Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to -$1.1 billion.

  • Tg Therapeutics' Retained Earnings rose 3093.42% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year increase of 3093.42%. This contributed to the annual value of -$1.5 billion for FY2024, which is 150.61% up from last year.
  • As of Q3 2025, Tg Therapeutics' Retained Earnings stood at -$1.1 billion, which was up 3093.42% from -$1.5 billion recorded in Q2 2025.
  • Over the past 5 years, Tg Therapeutics' Retained Earnings peaked at -$1.1 billion during Q1 2021, and registered a low of -$1.6 billion during Q2 2023.
  • Over the past 5 years, Tg Therapeutics' median Retained Earnings value was -$1.5 billion (recorded in 2022), while the average stood at -$1.4 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 4621.2% in 2021, then surged by 3093.42% in 2025.
  • Quarter analysis of 5 years shows Tg Therapeutics' Retained Earnings stood at -$1.3 billion in 2021, then fell by 14.93% to -$1.5 billion in 2022, then dropped by 1.67% to -$1.6 billion in 2023, then grew by 1.51% to -$1.5 billion in 2024, then grew by 27.74% to -$1.1 billion in 2025.
  • Its Retained Earnings was -$1.1 billion in Q3 2025, compared to -$1.5 billion in Q2 2025 and -$1.5 billion in Q1 2025.